Industry News
Cracking the epigenetic code
A team of researchers at The Australian National University is one step closer to better understanding how organisms function after discovering how epigenetic information is transmitted from one generation of cells to the next. [ + ]
Bioniche launches canine cancer product in NA
Bioniche Life Sciences (ASX:BNC) has launched its first canine cancer product, Immunocidin, in the US and Canadian markets. [ + ]
Bluechiip enters sample tracking tie-up
Bluechiip (ASX:BCT) has partnered with Swiss laboratory systems developer Inpeco, agreeing to explore jointly developing Inpeco products with integrated Bluechiip tracking chips. [ + ]
Grace announces additional patent notices of allowance for flash chromatography technology
WR Grace & Co announced today that the US Patent and Trademark Office has granted three additional notices of allowance related to the company’s Reveleris flash chromatography system. [ + ]
Naturally occurring compounds could fight ovarian cancer
A University of Canterbury (UC) research project, in collaboration with the University of Otago, Christchurch (formerly known as Christchurch School of Medicine), has shown some promising signs in the treatment of ovarian cancer. [ + ]
Cobalt-graphene could be a viable replacement for platinum catalysts
There’s a new contender in the race to find an inexpensive alternative to platinum catalysts for use in hydrogen fuel cells - a graphene sheet covered by cobalt and cobalt-oxide nanoparticles. [ + ]
Allied Healthcare's CardioCel used in first non-trial procedure
Allied Healthcare (ASX:AHZ) has reached a milestone with its CardioCel cardiovascular patch product, announcing its first surgical use outside of clinical trials. [ + ]
State finalists for Student Excellence Awards announced
The state finalists of the 2012 AusBiotech/GSK Student Excellence Awards have been announced. Sixteen promising research students competed for the chance to represent their state, and the six state finalists will now compete at the AusBiotech national conference to win a $7,000 travel grant. [ + ]
Volunteers sought for edible vaccine trials
Researchers from The University of Western Australia, Ondek and Sir Charles Gairdner Hospital are continuing a study into how the bacteria responsible for stomach ulcers, Helicobacter pylori, can be used as a carrier for ingestible vaccines. [ + ]
Bionomics presenting early Alpha 7 data
Bionomics (ASX:BNO) is presenting details of its its Alpha 7 program targeting Alzheimers and other neurodegenerative conditions at Neuroscience 2012, as it embarks on the hunt for a licensing deal. [ + ]
STA licenses treatment for cachexia-anorexia
Specialised Therapeutics Australia (STA) has negotiated commercialisation rights for a new drug to treat cachexia-anorexia, a serious condition linked with advanced cancers. [ + ]
CSL to conduct another $900m buyback
CSL (ASX:CSL) has announced another up to $900 million share buyback, and has affirmed its guidance for FY13. [ + ]
Non-invasive test for colorectal cancer shows promise
A new non-invasive test for colorectal cancer screening has demonstrated high sensitivity for detecting colorectal cancer; in particular, precancers that are most likely to develop into cancer. [ + ]
Thermo Fisher Scientific and Immundiagnostik collaborate on mass spectrometry-based clinical and research tools
Thermo Fisher Scientific and Immundiagnostik have announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine clinical analysis. [ + ]
Clinuvel data show SCENESSE accelerates repigmentation
The first published data from Clinuvel's (ASX:CUV) trial of SCENESSE in patients with skin condition vitiligo indicate that the treatment can help accelerate repigmentation of the skin. [ + ]
